Ep 32 - Antonio Linares Makes the Case for Hims as a 100x — From Here

Hims functions as a modern, customer-centric healthcare platform, effectively applying the "Costco algorithm"—a strategy of delivering high value at lower real prices—to disrupt a traditionally inflationary and fragmented healthcare system. By vertically integrating infrastructure and leveraging proprietary data, the company creates a digital twin for healthcare, enabling personalized, at-scale manufacturing of treatments. The expansion into peptide therapeutics, including GLP-1s, represents a significant growth vector that captures the current cultural zeitgeist while offering substantial longevity and performance benefits. This model shifts the company from a simple provider of generic medications to a sophisticated, tech-enabled platform. As the company scales, its ability to lower customer acquisition costs and increase lifetime value through synergistic, multi-subscription models positions it to fundamentally reshape how patients access and manage their health, potentially outperforming legacy systems through superior execution and data-driven iteration.